Acurx Pharmaceuticals logo

Acurx Pharmaceuticals

ACXP | NASDAQ
Chart Builder DCF Calculator
$0.94
-$0.02 (-2.08%)
At close: Nov 16, 2026, 4:00 PM ET
$1.04
+$0.10 (+10.64%)
After-hours: Nov 16, 2026, 7:36 PM ET
-2.08%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
35.8
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #637/1021 (Top 62%)

Key Statistics

Market Data

Market Cap $5.66M
1D Range
0.92 1.01
52W Range
0.92 6.63

Valuation (TTM)

PE -0.33
PB 0.00
EV/EBITDA N/A

Valuation (NTM)

Forward PE N/A
Forward PEG 0.00
Price Target $11.00
Loading financial charts...

Profile

Acurx Pharmaceuticals, Inc. functions as a clinical-stage biopharmaceutical firm focused on developing innovative antibiotic treatments for bacterial infections. The company's primary drug candidate i...

Sector Healthcare
Industry Biotechnology
Employees 4
IPO Date Jun 25, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$11.00
Upside
+1070.21%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.